AGIO
Agios Pharmaceuticals, Inc.
35.00$
+3.0%
vs. previous close
Closing price · As of: Sep 22, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 180.7% | 239.9% | 315.0% | 680.5% | 1.5% | 1.1% | 9.2% | 45,345.2% | 12.0% | 35.4% | 11.4% | 21.3% | |
| 100.0% | 100.0% | 100.0% | 100.0% | 98.5% | 98.9% | -9.2% | -45,345.2% | 88.0% | 64.6% | 88.6% | 78.7% | |
| 153.6% | 239.9% | 315.0% | 680.5% | 361.6% | 348.5% | 103.9% | 620,572.8% | 1,965.7% | 1,077.1% | 825.5% | 618.9% | |
| 29.3% | 60.9% | 72.6% | 165.4% | 120.9% | 112.0% | 73.4% | 293,281.7% | 854.4% | 447.0% | 429.6% | 333.7% | |
| 182.8% | 300.8% | 387.6% | 845.8% | 482.6% | 460.5% | 156.1% | 868,509.3% | 2,820.1% | 1,524.1% | 1,255.1% | 952.5% | |
| -82.8% | -200.8% | -287.6% | -745.8% | -384.0% | -361.6% | -165.3% | -913,854.5% | -2,732.1% | -1,459.5% | -1,166.5% | -873.9% | |
| 0.3% | 1.6% | 3.6% | 14.2% | 17.4% | 12.6% | 8.8% | 2,018.9% | 89.8% | – | – | – | |
| -82.5% | -199.1% | -284.0% | -731.6% | -366.6% | -349.0% | -162.1% | -860,948.1% | -1,627.8% | -1,312.6% | 1,967.1% | -765.9% | |
| -0.7% | -0.7% | -8.2% | -15.0% | 34.9% | -12.6% | 3.9% | -4,776,594.5% | -1,104.3% | 24.1% | 121.2% | -1.9% | |
| -81.9% | -199.1% | -284.0% | -731.6% | -366.6% | -349.0% | -161.1% | 3,875,280.7% | -1,627.8% | -1,312.6% | 1,845.9% | -764.0% | |
| -80.7% | -195.1% | -279.4% | -730.9% | -376.4% | -334.9% | -152.8% | -815,602.9% | -1,567.7% | -1,287.9% | 1,982.6% | -756.3% |
Data as of: September 22, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.